Medication use in the neonatal intensive care unit in a tertiary hospital in China from 2020 to 2023

Abstract Background The use of medication in the neonatal intensive care unit (NICU) is a complex field that requires special attention, as neonatal patients may have different sensitivities and responses to drugs than adults and older children. The administration of medication in the NICU must cons...

Full description

Saved in:
Bibliographic Details
Main Authors: Yi Wang, Linhong Song, Yanhua Wang, Jun Li, Yuanyuan Xie, Lei Yan, Huixia Zhou, Siqi Hu
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Italian Journal of Pediatrics
Subjects:
Online Access:https://doi.org/10.1186/s13052-025-02003-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849326007371169792
author Yi Wang
Linhong Song
Yanhua Wang
Jun Li
Yuanyuan Xie
Lei Yan
Huixia Zhou
Siqi Hu
author_facet Yi Wang
Linhong Song
Yanhua Wang
Jun Li
Yuanyuan Xie
Lei Yan
Huixia Zhou
Siqi Hu
author_sort Yi Wang
collection DOAJ
description Abstract Background The use of medication in the neonatal intensive care unit (NICU) is a complex field that requires special attention, as neonatal patients may have different sensitivities and responses to drugs than adults and older children. The administration of medication in the NICU must consider various factors, including the dosage of the medication, the route of administration, monitoring, and potential drug interactions. Methods In this study, we conducted a retrospective analysis of medication use in the neonatal intensive care unit of 122 preterm infants treated in our hospital from 2020 to 2023. Results Correlation analysis revealed that among perinatal clinical characteristics, birth weight was moderately positively correlated with gestational age, with a correlation coefficient greater than that of birth weight with the Apgar score. The top 3 medication types in the NICU were “vitamins, nutritional drugs, enzyme preparations and drugs that regulate water, electrolytes, and acid-base balance”, “blood hematopoietic system medications”, and “antimicrobial medications”. From 2020 to 2023, the most commonly used drugs in the NICU were vitamin AD (vitamin A and vitamin D) drops and calcium gluconate injections. In addition, we demonstrated that the most commonly prescribed off-label drugs were vitamins, water and electrolyte balance nutrition drugs, and blood circulation system drugs. Conclusions Our retrospective study will not only help identify and evaluate interventions to reduce medication errors but also aid healthcare systems and providers in understanding, implementing, and enhancing these interventions to improve the safety and quality of care for newborns. Nonetheless, further research is needed to assess the relative cost-effectiveness of various medication safety interventions to facilitate their adoption and implementation in the decision-making process.
format Article
id doaj-art-e0a3a7451bce42819c155ce909c06d94
institution Kabale University
issn 1824-7288
language English
publishDate 2025-05-01
publisher BMC
record_format Article
series Italian Journal of Pediatrics
spelling doaj-art-e0a3a7451bce42819c155ce909c06d942025-08-20T03:48:15ZengBMCItalian Journal of Pediatrics1824-72882025-05-015111910.1186/s13052-025-02003-wMedication use in the neonatal intensive care unit in a tertiary hospital in China from 2020 to 2023Yi Wang0Linhong Song1Yanhua Wang2Jun Li3Yuanyuan Xie4Lei Yan5Huixia Zhou6Siqi Hu7Institute of Pediatrics, Faculty of Pediatrics, The Seventh Medical Center of PLA General HospitalNational Engineering Laboratory for Birth Defect Prevention and Control of Key TechnologyInstitute of Pediatrics, Faculty of Pediatrics, The Seventh Medical Center of PLA General HospitalInstitute of Pediatrics, Faculty of Pediatrics, The Seventh Medical Center of PLA General HospitalInstitute of Pediatrics, Faculty of Pediatrics, The Seventh Medical Center of PLA General HospitalInstitute of Pediatrics, Faculty of Pediatrics, The Seventh Medical Center of PLA General HospitalNational Engineering Laboratory for Birth Defect Prevention and Control of Key TechnologyInstitute of Pediatrics, Faculty of Pediatrics, The Seventh Medical Center of PLA General HospitalAbstract Background The use of medication in the neonatal intensive care unit (NICU) is a complex field that requires special attention, as neonatal patients may have different sensitivities and responses to drugs than adults and older children. The administration of medication in the NICU must consider various factors, including the dosage of the medication, the route of administration, monitoring, and potential drug interactions. Methods In this study, we conducted a retrospective analysis of medication use in the neonatal intensive care unit of 122 preterm infants treated in our hospital from 2020 to 2023. Results Correlation analysis revealed that among perinatal clinical characteristics, birth weight was moderately positively correlated with gestational age, with a correlation coefficient greater than that of birth weight with the Apgar score. The top 3 medication types in the NICU were “vitamins, nutritional drugs, enzyme preparations and drugs that regulate water, electrolytes, and acid-base balance”, “blood hematopoietic system medications”, and “antimicrobial medications”. From 2020 to 2023, the most commonly used drugs in the NICU were vitamin AD (vitamin A and vitamin D) drops and calcium gluconate injections. In addition, we demonstrated that the most commonly prescribed off-label drugs were vitamins, water and electrolyte balance nutrition drugs, and blood circulation system drugs. Conclusions Our retrospective study will not only help identify and evaluate interventions to reduce medication errors but also aid healthcare systems and providers in understanding, implementing, and enhancing these interventions to improve the safety and quality of care for newborns. Nonetheless, further research is needed to assess the relative cost-effectiveness of various medication safety interventions to facilitate their adoption and implementation in the decision-making process.https://doi.org/10.1186/s13052-025-02003-wNeonatal intensive care unitOff-label drugClinical pharmacologyPharmacotherapyTrends over time
spellingShingle Yi Wang
Linhong Song
Yanhua Wang
Jun Li
Yuanyuan Xie
Lei Yan
Huixia Zhou
Siqi Hu
Medication use in the neonatal intensive care unit in a tertiary hospital in China from 2020 to 2023
Italian Journal of Pediatrics
Neonatal intensive care unit
Off-label drug
Clinical pharmacology
Pharmacotherapy
Trends over time
title Medication use in the neonatal intensive care unit in a tertiary hospital in China from 2020 to 2023
title_full Medication use in the neonatal intensive care unit in a tertiary hospital in China from 2020 to 2023
title_fullStr Medication use in the neonatal intensive care unit in a tertiary hospital in China from 2020 to 2023
title_full_unstemmed Medication use in the neonatal intensive care unit in a tertiary hospital in China from 2020 to 2023
title_short Medication use in the neonatal intensive care unit in a tertiary hospital in China from 2020 to 2023
title_sort medication use in the neonatal intensive care unit in a tertiary hospital in china from 2020 to 2023
topic Neonatal intensive care unit
Off-label drug
Clinical pharmacology
Pharmacotherapy
Trends over time
url https://doi.org/10.1186/s13052-025-02003-w
work_keys_str_mv AT yiwang medicationuseintheneonatalintensivecareunitinatertiaryhospitalinchinafrom2020to2023
AT linhongsong medicationuseintheneonatalintensivecareunitinatertiaryhospitalinchinafrom2020to2023
AT yanhuawang medicationuseintheneonatalintensivecareunitinatertiaryhospitalinchinafrom2020to2023
AT junli medicationuseintheneonatalintensivecareunitinatertiaryhospitalinchinafrom2020to2023
AT yuanyuanxie medicationuseintheneonatalintensivecareunitinatertiaryhospitalinchinafrom2020to2023
AT leiyan medicationuseintheneonatalintensivecareunitinatertiaryhospitalinchinafrom2020to2023
AT huixiazhou medicationuseintheneonatalintensivecareunitinatertiaryhospitalinchinafrom2020to2023
AT siqihu medicationuseintheneonatalintensivecareunitinatertiaryhospitalinchinafrom2020to2023